Olaregen to launch three doses of Excellagen wound healing gel
Generex Biotechnology’s subsidiary Olaregen Therapeutix is planning commercial launch of three dosing options for Excellagen wound conforming gel…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Jan 19
Generex Biotechnology’s subsidiary Olaregen Therapeutix is planning commercial launch of three dosing options for Excellagen wound conforming gel…
14 Jan 19
NanoVibronix has entered into a collaboration agreement with the Fritz Clinic, which operates 7 locations in North America…
14 Jan 19
Medical technology firm Awak Technologies has secured breakthrough device designation from the US Food and Drug Administration (FDA)…
11 Jan 19
Philips has realigned three of its reporting segments including diagnosis & treatment, connected care & health informatics, and…
11 Jan 19
ZOLL Medical, an Asahi Kasei Group subsidiary, has recently acquired Payor Logic, a company that develops accounts receivable…
11 Jan 19
Generex Biotechnology has signed a letter of intent (LOI) to acquire Medisource Partners, an FDA-registered medical and surgical…
10 Jan 19
Integrated healthcare holding firm Generex Biotechnology has signed a letter of intent (LOI) to acquire Pantheon Medical –…
09 Jan 19
IZI Medical Products, a major interventional radiology medical device company and portfolio company of Shore Capital Partners, has…
09 Jan 19
Medical technology company Hill-Rom has collaborated with technology firm Microsoft to expand digital health capabilities.
09 Jan 19
BioWave has launched BioWaveGO a new FDA cleared, over the counter (OTC) version of its popular, non-opioid, patented,…